These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 2690346)

  • 21. [Heart involvement and pulmonary arterial hypertension in patients with systemic sclerosis].
    Cikes N
    Reumatizam; 2010; 57(2):99-104. PubMed ID: 21875012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiac involvement in systemic sclerosis: Getting to the heart of the matter.
    Bruni C; Ross L
    Best Pract Res Clin Rheumatol; 2021 Sep; 35(3):101668. PubMed ID: 33736950
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiac involvement in progressive systemic sclerosis and polymyositis: a comparative study in 116 patients.
    Purice S; Luca R; Vintilă M; Tănăseanu S; Bălănescu E
    Med Interne; 1989; 27(3):209-13. PubMed ID: 2617074
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cardiomyopathy in murine models of systemic sclerosis.
    Venalis P; Kumánovics G; Schulze-Koops H; Distler A; Dees C; Zerr P; Palumbo-Zerr K; Czirják L; Mackevic Z; Lundberg IE; Distler O; Schett G; Distler JH
    Arthritis Rheumatol; 2015 Feb; 67(2):508-16. PubMed ID: 25371068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Points to consider when doing a trial primarily involving the heart.
    Allanore Y; Distler O; Walker UA; Khanna D; Furst DE; Meune C
    Rheumatology (Oxford); 2017 Sep; 56(suppl_5):v12-v16. PubMed ID: 28992169
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive noninvasive assessment of cardiac involvement in limited systemic sclerosis.
    Candell-Riera J; Armadans-Gil L; Simeón CP; Castell-Conesa J; Fonollosa-Pla V; García-del-Castillo H; Vaqué-Rafart J; Vilardell M; Soler-Soler J
    Arthritis Rheum; 1996 Jul; 39(7):1138-45. PubMed ID: 8670322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Cardiac involvement in systemic sclerosis.
    Anvari A; Graninger W; Schneider B; Sochor H; Weber H; Schmidinger H
    Arthritis Rheum; 1992 Nov; 35(11):1356-61. PubMed ID: 1445453
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Cardiac manifestations of diffuse systemic scleroderma. Apropos of 4 cases].
    Bennis A; Soulami S; Azzouzi L; Tahiri A; Chraibi N
    Ann Cardiol Angeiol (Paris); 1995 Mar; 44(3):119-24. PubMed ID: 7793849
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary heart disease in systemic sclerosis (scleroderma): advances in clinical and pathologic features, pathogenesis, and new therapeutic approaches.
    Botstein GR; LeRoy EC
    Am Heart J; 1981 Nov; 102(5):913-9. PubMed ID: 7030042
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival.
    Fernández-Codina A; Simeón-Aznar CP; Pinal-Fernandez I; Rodríguez-Palomares J; Pizzi MN; Hidalgo CE; Guillén-Del Castillo A; Prado-Galbarro FJ; Sarria-Santamera A; Fonollosa-Plà V; Vilardell-Tarrés M
    Rheumatol Int; 2017 Jan; 37(1):75-84. PubMed ID: 26497313
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrocardiographic markers for the prediction of ventricular arrhythmias in patients with systemic sclerosis.
    Sebestyén V; Szűcs G; Páll D; Ujvárosy D; Ötvös T; Csige I; Pataki T; Lőrincz I; Szabó Z
    Rheumatology (Oxford); 2020 Mar; 59(3):478-486. PubMed ID: 31943100
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assessment of myocardial fibrosis and microvascular damage in systemic sclerosis by magnetic resonance imaging and coronary angiotomography.
    Rodríguez-Reyna TS; Morelos-Guzman M; Hernández-Reyes P; Montero-Duarte K; Martínez-Reyes C; Reyes-Utrera C; Vazquez-La Madrid J; Morales-Blanhir J; Núñez-Álvarez C; Cabiedes-Contreras J
    Rheumatology (Oxford); 2015 Apr; 54(4):647-54. PubMed ID: 25239881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiovascular magnetic resonance in systemic sclerosis: "Pearls and pitfalls".
    Mavrogeni SI; Schwitter J; Gargani L; Pepe A; Monti L; Allanore Y; Matucci-Cerinic M
    Semin Arthritis Rheum; 2017 Aug; 47(1):79-85. PubMed ID: 28522072
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Assessment of heart involvement.
    Ferri C; Emdin M; Nielsen H; Bruhlmann P
    Clin Exp Rheumatol; 2003; 21(3 Suppl 29):S24-8. PubMed ID: 12889218
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Systemic sclerosis. A clinical overview.
    Generini S; Fiori G; Moggi Pignone A; Matucci Cerinic M; Cagnoni M
    Adv Exp Med Biol; 1999; 455():73-83. PubMed ID: 10599326
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The heart in scleroderma.
    Champion HC
    Rheum Dis Clin North Am; 2008 Feb; 34(1):181-90; viii. PubMed ID: 18329539
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Cardiac involvement in progressive systemic sclerosis (PSS)].
    Pinto S; Magherini A
    Boll Soc Ital Cardiol; 1981; 26(12):2097-9. PubMed ID: 6224498
    [No Abstract]   [Full Text] [Related]  

  • 38. The heart in systemic sclerosis.
    Steen V
    Curr Rheumatol Rep; 2004 Apr; 6(2):137-40. PubMed ID: 15016344
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-invasive diagnostic and functional evaluation of cardiac and pulmonary involvement in systemic sclerosis.
    Sergiacomi G; De Nardo D; Capria A; Manenti G; Fabiano S; Borzi M; De Sanctis G; Konda D; Sperandio M; Schillaci O; Masala S; Simonetti G; Fontana L
    In Vivo; 2004; 18(2):229-35. PubMed ID: 15113051
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular complications of systemic sclerosis: What to look for.
    Mani P; Gonzalez D; Chatterjee S; Faulx MD
    Cleve Clin J Med; 2019 Oct; 86(10):685-695. PubMed ID: 31597076
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.